Leaders of 3 health technology assessment organizations convene working group and steering committee to critically and independently research new ...
Latest News
The 2025 call for nominations to join expert and advisory committees at Canada’s Drug Agency will be open from March 3 to March 31, 2025.
These ...
Canada’s Drug Agency has officially opened its call for nominations for the position of Chair of its Board of Directors. This is a unique opportunity ...
Recommendations will help organizations that appraise new drugs establish whether their use will result in longer-term benefits for patients
Four ...
Canada’s Drug Agency is seeking to expand the group of scientists who contribute their expertise to our organization and help us power evidence ...
Consultation status: ClosedConsultation period: January 6 to February 6, 2025
Canada’s Drug Agency is outlining additional plans to modernize the drug ...
Upcoming Events
All Upcoming EventsThe Proposed Pan-Canadian Guidance for Newborn Screening: What We Heard
10th Annual Forum: Pathways to Access and Reimbursement
Symposium 2024
Symposium 2024 is a 3-day hybrid event that gathers leaders from across Canada with expertise in policy, industry, health technology assessment, patient advocacy, medicine, public health, and communications. The theme of Symposium 2024 is From Disruption to Opportunity: Embracing Change in Health Care.
